Photo of Slates C. Veazey

Slates is a member of Bradley’s Cannabis Industry team, advising clients on a variety of cannabis issues and in a wide range of sectors. From individuals and entities interested in participating in the new Mississippi medical cannabis program to non-plant-touching companies impacted by that emerging market, Slates and his partners provide the full suite of services that Bradley offers to its many other clients -- but with a specific understanding of the ever-changing cannabis industry. His work has been featured in The National Law Journal, JD Supra, and the Cannabis Business Executive. Slates also has been quoted by the Mississippi Business Journal and Mississippi Today regarding Mississippi’s medical cannabis program.

“What a long, strange trip it’s been.”

When we launched Budding Trends years ago as a modest little blog focused on cannabis law, the idea that we’d one day spend serious time tracking potential widespread access to psychedelics was, to put it mildly, not part of the original pitch deck. And yet, here we are.

This is the tenth of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen will address how rescheduling affects various areas of the law and our daily lives. Enjoy the run.

There were massive cheers in the

This is the ninth of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen will address how rescheduling affects various areas of the law and our daily lives. Enjoy the run.

On April 22, 2026, Acting Attorney

This is the eighth of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen will address how rescheduling affects various areas of the law and our daily lives. Enjoy the run.

Another industry that isn’t currently in

After years of false starts, stalled hearings, a retired judge, a fired attorney general, and a president who last weekend told officials to stop “slow-walking” on cannabis, we finally have something to talk about. Effective April 22, 2026, Acting Attorney General Todd Blanche signed a final order moving FDA-approved marijuana products and state-licensed medical marijuana

Here at Budding Trends, we like to roll up our “Top 10 Weed Roundup” between the sacred and renowned 420 holidays. Each year, we pack a recap post with 10 highly read blog posts since the previous 420 to see what’s shakin’ on shakedown street over the last year — and we have seen

As the frozen precipitation is continuing to thaw across the upper part of Mississippi, the Mississippi legislature continues to forge ahead in this year’s legislative session. If you tuned into the webinar we hosted on January 14, you heard our Mississippi government affairs colleague, Spencer Ritchie, discuss the cannabis-related legislation he expected to see this

It’s that time of year again. Our annual round-up featuring some of the most read content on Budding Trends in the past year. This year’s edition has a little something for everyone: marijuana, hemp, mushrooms, state law, federal law, banking, intellectual property, and more!

Before we dive right in, we want to plug our January

As we close the book on 2025 and look ahead, we can’t help but feel a strong sense that we’ve been here before. 

On the one hand, with the federal government potentially eradicating consumable hemp in November and the president ordering urgent action on marijuana rescheduling in December, it may not be an exaggeration to say

Are you not entertained? In a much-anticipated ceremony in the Oval Office, President Trump signed an executive order that (1) directs the attorney general to expeditiously reschedule marijuana to Schedule III and (2) instructs senior White House staff to work with Congress to revise the statutory definition of final hemp-derived cannabinoid products.

The first of